We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
(+41%)
Cap. Flow
+$327M
Cap. Flow
% of AUM
38.29%
Top 10 Holdings %
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$13.6M |
| 2 |
Merck
MRK
|
+$12.5M |
| 3 |
Intuitive Surgical
ISRG
|
+$11.1M |
| 4 |
DOCU
DocuSign
DOCU
|
+$10.9M |
| 5 |
Insulet
PODD
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nasdaq
NDAQ
|
+$7.26M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$6.86M |
| 3 |
Incyte
INCY
|
+$6.31M |
| 4 |
Fidelity National Information Services
FIS
|
+$5.73M |
| 5 |
AbbVie
ABBV
|
+$4.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Consumer Discretionary | 17.68% |
| 3 | Healthcare | 16.13% |
| 4 | Industrials | 12.13% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Canadian Natural Resources
CNQ
$94.8B
| $336K | 0.04% |
+10,398
| New | +$318K |
|
477
Stanley Black & Decker
SWK
$15.3B
| $335K | 0.04% |
+4,006
| New | +$371K |
|
478
PVH
PVH
$3.99B
| $331K | 0.04% |
+4,320
| New | +$357K |
|
479
Brunswick
BC
$5.26B
| $330K | 0.04% |
4,179
-1,564
| -27% | -$129K |
|
480
ZIM Integrated Shipping Services
ZIM
$3.18B
| $329K | 0.04% |
31,475
-103,549
| -77% | -$1.32M |
|
481
Exponent
EXPO
$3.21B
| $328K | 0.04% |
+3,833
| New | +$347K |
|
482
Watts Water Technologies
WTS
$12.6B
| $319K | 0.04% |
+1,848
| New | +$338K |
|
483
Power Integrations
POWI
$3.29B
| $319K | 0.04% |
4,180
+1,076
| +35% | +$92.1K |
|
484
Under Armour Class C
UA
$2.67B
| $318K | 0.04% |
49,798
+19,939
| +67% | +$137K |
|
485
Tower Semiconductor
TSEM
$25.4B
| $317K | 0.04% |
+12,915
| New | +$414K |
|
|
HCP
486
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $315K | 0.04% |
13,816
-20,621
| -60% | -$560K |
|
487
Visteon
VC
$2.75B
| $314K | 0.04% |
+2,273
| New | +$327K |
|
488
Twist Bioscience
TWST
$6.84B
| $306K | 0.04% |
+15,115
| New | +$332K |
|
489
Talos Energy
TALO
$2.35B
| $306K | 0.04% |
+18,585
| New | +$299K |
|
490
Huntington Ingalls Industries
HII
$12.7B
| $305K | 0.04% |
+1,492
| New | +$329K |
|
491
Paylocity
PCTY
$8.04B
| $301K | 0.04% |
1,658
+78
| +5% | +$15.7K |
|
492
Synaptics
SYNA
$3.99B
| $298K | 0.03% |
3,331
-1,663
| -33% | -$146K |
|
493
Seadrill
SDRL
$2.69B
| $296K | 0.03% |
+6,614
| New | +$308K |
|
494
FIGS
FIGS
$1.88B
| $295K | 0.03% |
+49,927
| New | +$332K |
|
495
Sanmina
SANM
$11B
| $292K | 0.03% |
+5,379
| New | +$303K |
|
496
Arcus Biosciences
RCUS
$3.61B
| $292K | 0.03% |
+16,265
| New | +$327K |
|
497
Vale
VALE
$62.6B
| $290K | 0.03% |
+21,660
| New | +$295K |
|
498
Alcoa
AA
$12.5B
| $287K | 0.03% |
9,890
+2,711
| +38% | +$85K |
|
499
Pool Corp
POOL
$7.31B
| $286K | 0.03% |
+804
| New | +$293K |
|
500
Old Dominion Freight Line
ODFL
$43.8B
| $286K | 0.03% |
+1,396
| New | +$282K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2023 Portfolio in Review
As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.
- Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
- Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
- Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
- Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
- Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
- Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
- Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.
Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.